January 14, 2026
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 23.55 billion in 2025 to USD 36.29 billion by 2035, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and...
April 21, 2026
According to market projections, the house calls sector is expected to grow from USD 2.69 billion in 2024 to USD 5.23 billion by 2034, reflecting a CAGR of 6.89%. The market is growing due to rising demand for convenient, at-home healthcare services ...
April 23, 2026
Drug Delivery Devices Market ( By Product: Inhalers, Injection Devices, Implants, Topical Delivery System, Oral Delivery System, Infusion Pumps; By Application: Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System ...
April 21, 2026
Market insights predict the global robotic surgery industry will increase from USD 13.79 billion in 2025 to USD 63.73 billion by 2035, achieving a CAGR of 16.54%. In 2024, North America led the market. The increasing number of surgical procedures con...
April 21, 2026
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific show...
April 21, 2026
Based on market forecasts, the global chronic disease treatment market, projected at USD 8.37 billion in 2024, is expected to reach USD 38.02 billion by 2034, growing at a CAGR of 16.34% over the forecast period.The rising prevalence of chronic disor...
April 21, 2026
The global market is driven by the increasing healthcare costs and awareness. North America led due to the presence of robust value-based care models in CCM....
February 04, 2026
According to our projections, the chronic pain therapy solutions for joints market was valued at USD 5.15 billion in 2025 and reached USD 5.4 billion in 2026, with projections indicating growth to USD 8.28 billion by 2035, expanding at a CAGR of 4.86...
April 21, 2026
According to market projections, the global chronic lower back pain market, valued at USD 2.69 billion in 2024, is anticipated to reach USD 6.69 billion by 2034, growing at a CAGR of 9.52% over the next decade. The increasing geriatric population wit...
April 09, 2026
Smart Drug Delivery Systems Market (By Product Type: Inhalers, Smart Injectable Devices, Smart Infusion Pumps, Connected Drug Delivery Devices, Implantable Drug Delivery Systems, Transdermal Drug Delivery Systems; By Technology: IoT-based Systems, Bl...
April 21, 2026
According to market estimations the global medical device gaskets & seals sector is projected to grow from USD 0.92 billion in 2023 to USD 1.57 billion by 2034 at a 5% CAGR. Growth is driven by medical innovations, rising surgeries, 3D printing...
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
April 09, 2026
Pulmonary Function Testing Systems Market (By Type: Spirometers, Peak Flow Meters, Gas Analyzers, Oximeters, Others; By End-User: Hospitals, Clinics, Home Care, Ambulatory Surgical Centers (ASCs); By Application: Chronic Obstructive Pulmonary Disease...
April 21, 2026
Projections indicate that, progressive pulmonary fibrosis (PPF) treatment industry is projected to rise from USD 0.6 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 15.21% over the next decade. The Progressive Pulmonary Fibrosis (PP...
April 21, 2026
Based on market forecasts, the disease management apps sector will expand from USD 11.30 billion in 2025 to USD 30.25 billion by 2035, experiencing a CAGR of 10.35%.The rising prevalence of chronic disorders and the growing demand for telemedicine dr...
April 21, 2026
According to market projections, the global respiratory disease vaccine market, valued at USD 65.72 billion in 2025, is anticipated to reach USD 98.41 billion by 2035, growing at a CAGR of 4.12% over the next decade. The rising prevalence of respirat...
April 21, 2026
According to forecasts, the global kidney organ-on-a-chip market will grow from USD 192 million in 2024 to USD 1314.52 million by 2034, with an expected CAGR of 21.27%. A rise in CKD cases and advances in materials are fueling the global market. Nort...
April 21, 2026
The global market is driven by a rise in SCD prevalence and R&D activities. North America dominated the market due to the increasing R&D investment from various companies....
April 21, 2026
According to market projections, the global liver disease therapeutics market, valued at USD 26.54 billion in 2025, is anticipated to reach USD 45.25 billion by 2035, growing at a CAGR of 5.48% over the next decade. The liver disease therapeutics mar...
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as ...
April 21, 2026
Projections indicate that, predictive disease analytics industry is projected to rise from USD 3.12 billion in 2024 to USD 24.23 billion by 2034, reflecting a CAGR of 22.75% over the next decade. The predictive analytics majorly contributes to improv...
April 21, 2026
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), ...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of p...
April 21, 2026
According to market projections, the protein labeling sector is expected to grow from USD 2.67 billion in 2024 to USD 6.02 billion by 2034, reflecting a CAGR of 8.48%. Protein labeling is used in research and diagnosis of various diseases, which driv...
April 21, 2026
Projections indicate that, the global rare disease treatment market will increase from USD 195.21 billion in 2024 to USD 587.08 billion by 2034, experiencing a CAGR of 11.64% over the next 10 years.The rising prevalence of rare diseases and growing r...
January 29, 2026
Based on market forecasts, the global infectious disease testing market, projected at USD 29.04 billion in 2025, is expected to reach USD 53.19 billion by 2035, growing at a CAGR of 6.24% over the forecast period. The infectious disease testing marke...
February 05, 2026
Market insights predict the global magnetic resonance imaging (MRI) industry will increase from USD 7.54 billion in 2025 to USD 14.18 billion by 2035, achieving a CAGR of 6.52%. It is anticipated that rising disease prevalence will have a significant...
April 21, 2026
According to market projections, the microRNA market will increase from $2.05 billion in 2025 to $6.89 billion by 2035, including the dominant market share held by North America at 41.6% in 2025 and the rapidly expanding Asia Pacific region, which is...
April 21, 2026
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COP...
April 01, 2026
Veterinary Vaccines Market (By Animal Type: Production Animals, Poultry vaccines, Companion Animals, Aquaculture, Other Livestock, Wildlife / Zoo & Equine specialty; By Vaccine Type / Technology: Live-Attenuated Vaccines, Inactivated Vaccines, Re...
April 21, 2026
Market insights predict, the autoimmune disease diagnostics industry is expected to grow from USD 5.75 billion in 2024 to USD 10.5 billion by 2034, driven by a CAGR of 6.22%. Globally, rising incidences and breakthroughs in technologies in autoimmune...
April 21, 2026
According to market projections, the lysosomal storage disease sector is expected to grow from USD 8.61 billion in 2024 to USD 13.91 billion by 2034, reflecting a CAGR of 4.93%. The lysosomal storage disease market is expanding due to increasing...
April 21, 2026
Forecasts suggest that the digital biomarkers market will expand from USD 4.15 billion in 2024 to USD 32.37 billion by 2034, with a CAGR of 22.74% during this period. The rise has been attributed to the growing need for remote patient monitoring serv...
April 21, 2026
According to market projections, the global drug-eluting balloon catheters market, valued at USD 1.42 billion in 2024, is anticipated to reach USD 4.02 billion by 2034, growing at a CAGR of 11.1% over the next decade. The increasing cases of cardiova...
February 03, 2026
Projections indicate that, the global organoids and spheroids market will increase from USD 1.22 billion in 2025 to USD 9.77 billion by 2035, experiencing a CAGR of 23.13% over the next 10 years. Advances in genome editing technologies, automation, m...
April 21, 2026
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
April 21, 2026
Based on market forecasts, the inflammatory bowel disease treatment sector will expand from USD 21.01 billion in 2024 to USD 35.88 billion by 2034, experiencing a CAGR of 5.5%. The Inflammatory Bowel Disease (IBD) treatment market focuses on medicati...
April 21, 2026
Market insights predict, the veterinary infectious disease diagnostics industry is expected to grow from USD 2.68 billion in 2024 to USD 5.76 billion by 2034, driven by a CAGR of 7.95%.The growing infectious disease cases and awareness about animal...
January 14, 2026
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 7.49 billion in 2025, is anticipated to reach USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2023, medi...
March 18, 2026
Projections indicate that, point-of-care infectious disease testing industry is projected to rise from USD 12.42 billion in 2025 to USD 18.99 billion by 2035, reflecting a CAGR of 4.34% over the next decade. The point-of-care infectious disease testi...
April 21, 2026
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.23 billion in 2024 to USD 6 billion by 2034, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies market...
April 21, 2026
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
April 02, 2026
Blood-Based Biomarker for Alzheimer’s Disease Diagnostics Market (By Biomarker Type: Amyloid-Based Biomarkers, Tau-Based Biomarkers, Neurodegeneration Biomarkers, Inflammatory Biomarkers, Other Emerging Biomarkers; By Technology Platform: Immun...
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more rel...
April 21, 2026
Projections indicate that, the global sandhoff disease treatment market will increase from USD 260 million in 2024 to USD 456.42 million by 2034, experiencing a CAGR of 5.75% over the next 10 years. The Sandhoff disease treatment market is expanding ...
February 19, 2026
According to our forecasts, the invasive fungal disease (IFD) drugs market was valued at USD 3.11 billion in 2025 and is projected to grow from USD 3.29 billion in 2026 to USD 5.34 billion by 2035, expanding at a CAGR of 5.55% during 2026–2035....
April 21, 2026
Based on market forecasts, the global medical imaging market, projected at USD 41.64 billion in 2024, is expected to reach USD 67.87 billion by 2034, growing at a CAGR of 4.99% over the forecast period. The rising prevalence of chronic disorders, inc...
April 21, 2026
Market insights predict the global medical foods for orphan disease industry will increase from USD 8.84 billion in 2024 to USD 14.65 billion by 2034, achieving a CAGR of 5.2%. The market is growing due to rising health awareness, demand for personal...
April 21, 2026
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabo...
April 21, 2026
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
April 09, 2026
Biomarkers Market (By Type: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers; By Disease: Cancer, Neurological Diseases, Immunological Diseases, Cardiovascular Diseases, Others; By Application: Drug Discovery & Development, Personali...
April 21, 2026
Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand f...
March 13, 2026
According to market projections, the pacemeter sector is expected to grow from USD 5.65 billion in 2025 to USD 8.17 billion by 2035, reflecting a CAGR of 3.75%.The market is growing due to rising incidence of cardiac disorders an aging population. Te...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
March 16, 2026
Projections indicate that, infectious diseases industry is projected to rise from USD 23 billion in 2025 to USD 40.42 billion by 2035, reflecting a CAGR of 5.8% over the next decade. The continuous emergence of various pathogens, resulting in persist...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com